miR‑199a decreases Neuritin expression involved in the development of Alzheimer's disease in APP/PS1 mice

Song,Dandan; Li,Guoxiang; Hong,Yu; Zhang,Pan; Zhu,Jingling; Yang,Lei; Huang,Jin

doi:10.3892/ijmm.2020.4602

miR‑199a decreases Neuritin expression involved in the development of Alzheimer's disease in APP/PS1 mice

Authors:
- Dandan Song
- Guoxiang Li
- Yu Hong
- Pan Zhang
- Jingling Zhu
- Lei Yang
- Jin Huang
View Affiliations

Affiliations: The Key Laboratory of Xinjiang Endemic and Ethnic Diseases and Department of Biochemistry, Shihezi University School of Medicine, Shihezi, Xinjiang 832002, P.R. China, Department of Prevention Medicine, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 310036, P.R. China
Published online on: May 12, 2020 https://doi.org/10.3892/ijmm.2020.4602
Pages: 384-396
Copyright: © Song et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neuritin plays an important role in neural development and plasticity. A recent study demonstrated that increasing Neuritin levels attenuated synaptic damage in mice with Alzheimer's disease (AD), which exhibit a decreased Neuritin expression. However, it remains unclear as to whether Neuritin expression is regulated by microRNAs (miRNAs or miRs) in AD. In the present study, it was found that miR‑199a decreased Neuritin expression and was therefore involved in the development of AD. Subsequently, differentially expressed miRNAs in AD from datasets and the literature were recruited, and those that could bind Neuritin were predicted using bioinformatics analysis. The present study then focused on the candidate miRNAs that were highly associated with Neuritin and were upregulated in AD. The expression patterns of the candidate miRNAs and Neuritin in the hippocampus and cortex of APP/PS1 (AD model) mice at different stages were then detected and analyzed. It was found that miR‑199a expression was significantly increased in the early stages of AD and was negatively associated with Neuritin expression. Furthermore, it was revealed that the decreased Neuritin expression was due to the direct targeting of the Neuritin 3'‑UTR by miR‑199a. Finally, the association between the spatial memory capacity of APP/PS1 mice and the changes in miR‑199a and Neuritin expression protein was investigated. On the whole, the data of the present study suggest that miR‑199a is involved in the development of AD by regulating Neuritin expression.

View Figures

View References

1	Nedivi E, Hevroni D, Naot D, Israeli D and Citri Y: Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature. 363:718–722. 1993. View Article : Google Scholar : PubMed/NCBI
2	Nedivi E, Wu GY and Cline HT: Promotion of dendritic growth by CPG15, an activity-induced signaling molecule. Science. 281:1863–1866. 1998. View Article : Google Scholar : PubMed/NCBI
3	Naeve GS, Ramakrishnan M, Kramer R, Hevroni D, Citri Y and Theill LE: Neuritin: A gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc Natl Acad Sci USA. 94:2648–2653. 1997. View Article : Google Scholar : PubMed/NCBI
4	Cantallops I, Haas K and Cline HT: Postsynaptic CPG15 promotes synaptic maturation and presynaptic axon arbor elaboration in vivo. Nat Neurosci. 3:1004–1011. 2000. View Article : Google Scholar : PubMed/NCBI
5	Javaherian A and Cline HT: Coordinated motor neuron axon growth and neuromuscular synaptogenesis are promoted by CPG15 in vivo. Neuron. 45:505–512. 2005. View Article : Google Scholar : PubMed/NCBI
6	Karamoysoyli E, Burnand RC, Tomlinson DR and Gardiner NJ: Neuritin mediates nerve growth factor-induced axonal regeneration and is deficient in experimental diabetic neuropathy. Diabetes. 57:181–189. 2008. View Article : Google Scholar
7	Fargo KN, Alexander TD, Tanzer L, Poletti A and Jones KJ: Androgen regulates neuritin mRNA levels in an in vivo model of steroid-enhanced peripheral nerve regeneration. J Neurotrauma. 25:561–566. 2008. View Article : Google Scholar : PubMed/NCBI
8	Zhao QR, Lu JM, Yao JJ, Zhang ZY, Ling C and Mei YA: Neuritin reverses deficits in murine novel object associative recognition memory caused by exposure to extremely low-frequency (50 Hz) electromagnetic fields. Sci Rep. 5:117682015. View Article : Google Scholar : PubMed/NCBI
9	Zhang Y, Zhang S, Xian L, Tang J, Zhu J, Cui L, Li S, Yang L and Huang J: Expression and purification of recombinant human neuritin from Pichia pastoris and a partial analysis of its neurobiological activity in vitro. Appl Microbiol Biotechnol. 99:8035–8043. 2015. View Article : Google Scholar : PubMed/NCBI
10	Gao R, Li X, Xi S, Wang H, Zhang H, Zhu J, Shan L, Song X, Luo X, Yang L and Huang J: Exogenous Neuritin promotes nerve regeneration after acute spinal cord injury in rats. Hum Gene Ther. 27:544–554. 2016. View Article : Google Scholar : PubMed/NCBI
11	Wang H, Li X, Shan L, Zhu J, Chen R, Li Y, Yuan W, Yang L and Huang J: Recombinant hNeuritin promotes structural and functional recovery of sciatic nerve injury in rats. Front Neurosci. 10:5892016. View Article : Google Scholar
12	Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S and Van der Flier WM: Alzheimer's disease. Lancet. 388:505–517. 2016. View Article : Google Scholar : PubMed/NCBI
13	Choi Y, Lee K, Ryu J, Kim HG, Jeong AY, Woo RS, Lee JH, Hyun JW, Hahn S, Kim JH and Kim HS: Neuritin attenuates cognitive function impairments in tg2576 mouse model of Alzheimer's disease. PLoS One. 9:e1041212014. View Article : Google Scholar : PubMed/NCBI
14	An K, Jung JH, Jeong AY, Kim HG, Jung SY, Lee K, Kim HJ, Kim SJ, Jeong TY, Son Y, et al: Neuritin can normalize neural deficits of Alzheimer's disease. Cell Death Dis. 5:e15232014. View Article : Google Scholar : PubMed/NCBI
15	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
16	Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114. 2008. View Article : Google Scholar : PubMed/NCBI
17	Chang TC and Mendell JT: MicroRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet. 8:215–239. 2007. View Article : Google Scholar : PubMed/NCBI
18	Li F, Wei G, Bai Y, Li Y, Huang F, Lin J, Hou Q, Deng R, Zhou JH, Zhang SX and Chen DF: MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin. Brain Res. 1627:177–188. 2015. View Article : Google Scholar : PubMed/NCBI
19	Gao R, Wang L, Sun J, Nie K, Jian H, Gao L, Liao X, Zhang H, Huang J and Gan S: MiR-204 promotes apoptosis in oxidative stress-induced rat Schwann cells by suppressing neuritin expression. FEBS Lett. 588:3225–3232. 2014. View Article : Google Scholar : PubMed/NCBI
20	Shen NN, Zhang ZL, Li Z, Zhang C, Li H, Wang JL, Wang J and Gu ZC: Identification of microRNA biomarkers in atrial fibrillation: A protocol for systematic review and bioinformatics analysis. Medicine (Baltimore). 98:e165382019. View Article : Google Scholar
21	Lee ST, Chu K, Jung KH, Kim JH, Huh JY, Yoon H, Park DK, Lim JY, Kim JM, Jeon D, et al: MiR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann Neurol. 72:269–277. 2012. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
23	Morris R: Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 11:47–60. 1984. View Article : Google Scholar : PubMed/NCBI
24	Putz U, Harwell C and Nedivi E: Soluble CPG15 expressed during early development rescues cortical progenitors from apoptosis. Nat Neurosci. 8:322–331. 2005. View Article : Google Scholar : PubMed/NCBI
25	Fujino T, Leslie JH, Eavri R, Chen JL, Lin WC, Flanders GH, Borok E, Horvath TL and Nedivi E: CPG15 regulates synapse stability in the developing and adult brain. Genes Dev. 25:2674–2685. 2011. View Article : Google Scholar : PubMed/NCBI
26	Corriveau RA, Shatz CJ and Nedivi E: Dynamic regulation of cpg15 during activity-dependent synaptic development in the mammalian visual system. J Neurosci. 19:7999–8008. 1999. View Article : Google Scholar : PubMed/NCBI
27	Fujino T, Wu Z, Lin WC, Phillips MA and Nedivi E: cpg15 and cpg15-2 constitute a family of activity-regulated ligands expressed differentially in the nervous system to promote neurite growth and neuronal survival. J Comp Neurol. 507:1831–1845. 2008. View Article : Google Scholar : PubMed/NCBI
28	Hansra GK, Popov G, Banaczek PO, Vogiatzis M, Jegathees T, Goldbury CS and Cullen KM: The neuritic plaque in Alzheimer's disease: Perivascular degeneration of neuronal processes. Neurobiol Aging. 82:88–101. 2019. View Article : Google Scholar : PubMed/NCBI
29	Gouras GK, Olsson TT and Hansson O: β-Amyloid peptides and amyloid plaques in Alzheimer's disease. Neurotherapeutics. 12:3–11. 2015. View Article : Google Scholar
30	Theofilas P, Ehrenberg AJ, Nguy A, Thackrey JM, Dunlop S, Mejia MB, Alho AT, Paraizo Leite RE, Rodriguez RD, Suemoto CK, et al: Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: A quantitative study in humans. Neurobiol Aging. 61:1–12. 2018. View Article : Google Scholar
31	Lacosta AM, Insua D, Badi H, Pesini P and Sarasa M: Neurofibrillary tangles of Aβx-40 in Alzheimer's disease brains. J Alzheimers Dis. 58:661–667. 2017. View Article : Google Scholar
32	Fainstein N, Dan-Goor N and Ben-Hur T: Resident brain neural precursor cells develop age-dependent loss of therapeutic functions in Alzheimer's mice. Neurobiol Aging. 72:40–52. 2018. View Article : Google Scholar : PubMed/NCBI
33	Friedman E, Lerer B and Kuster J: Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning. Pharmacol Biochem Behav. 19:309–312. 1983. View Article : Google Scholar : PubMed/NCBI
34	Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S, Rothman R, Sierksma AS, Thathiah A, Greenberg D, et al: Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med. 5:1613–1634. 2013. View Article : Google Scholar : PubMed/NCBI
35	Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, Stähler C, et al: A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 14:R782013. View Article : Google Scholar : PubMed/NCBI
36	Hébert SS, Wang WX, Zhu Q and Nelson PT: A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis. 35:335–348. 2013. View Article : Google Scholar : PubMed/NCBI
37	Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE and Zhou XJ: Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One. 5:e88982010. View Article : Google Scholar : PubMed/NCBI